Researchers found that in specific types of breast cancer, changes in SULT1E1 and HIF1α factors can impact estrogen levels and tissue damage. Testing drug combinations targeting SULT1E1 may offer protective benefits in breast cancer treatment.
Researchers studied Lupiwighteone (Lup) in drug-resistant leukemia cells. Lup reversed Multidrug Resistance (MDR) in K562 cells. Potential mechanism for cancer treatment. Important for overcoming chemotherapy resistance.
Korean mistletoe lectin (VCA) enhances breast cancer cell apoptosis by influencing M1 and M2 macrophage polarization. Results suggest potential for VCA as an anti-cancer agent.
Researchers studied natural compounds, such as , , and , for treating aggressive brain tumor GBM. These compounds reduced tumor growth, migration, inflammation, and oxidative stress, offering a promising alternative to traditional treatments for better patient outcomes.
New fibrous materials were created from poly(3-hydroxybutyrate), HA, Ch, MO, and HP extracts using electrospinning. They showed high antioxidant, antibacterial, and anticancer properties, making them valuable for cancer therapy and wound dressings.
Researchers studied the herb pair Scutellaria barbata and Scleromitrion diffusum for their anti-tumor effects on triple-negative breast cancer. Understanding their molecular mechanisms can lead to new treatment options.
Study found that Annona muricata has potential anticancer activity. Nano formulation of its extract showed promise against oral cancer cells. Important for potential cancer treatment development.
Piperine from black pepper shows potential in overcoming drug resistance in cancer cells by targeting key pathways and enhancing drug bioavailability. It can improve the effectiveness of chemotherapy when used with other agents.